Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany

• Main Authors: Daniel Molnar (Author), Anastassia Anastassopoulou (Author), Barbara Poulsen Nautrup (Author), Ruprecht Schmidt-Ott (Author), Martin Eichner (Author), Markus Schwehm (Author), Gael Dos Santos (Author), Bernhard Ultsch (Author), Rafik Bekkat-Berkani (Author), Alfred von Krempelhuber (Author), Ilse Van Vlaenderen (Author), Laure-Anne Van Bellinghen (Author)
• Format: Book
• Published: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Seasonal influenza causes many cases and related deaths in Europe annually, despite ongoing vaccination programs for older adults and people at high-risk of complications. Children have the highest risk of infection and play a key role in disease transmission. Our cost-utility analysis, based on a d...